Read the latest news about BioAlfa, a European project focused on investigating whether certain blood factors that have been associated with aging or brain rejuvenation in mice may become a future in potential therapeutic targets in humans to fight Alzheimer's disease.
Dr Marc Suárez-Calvet explains his experience and the current stage of the project that he has led with European funding
The aim of the conferences is to bring scientific research closer to people
The aim of the project, entitled AlfaAge, is to identify pro-ageing and pro-youthful blood biomarkers in different age groups.
The project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie action grant agreement No 752310.